drugset
drugset / Trial / NCT01583023

Using Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Bipolar Depression

NCT01583023 ↗

Phase 4 Unknown 45 enrolled McGill University Health Centre/Research Institute of the McGill University Health Centre
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate whether repetitive transcranial magnetic stimulation (rTMS) treatment is an effective adjunct treatment to mood stabilizers and Bupropion.

Timeline

Start
2014-04
Primary completion
2015-04
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule 300 mg —

Indications

bipolar disorder